Growth Metrics

Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025)

Myomo filings provide 10 years of Liabilities and Shareholders Equity readings, the most recent being $34.1 million for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 108.9% to $34.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $155.9 million, a 145.04% increase, with the full-year FY2024 number at $42.2 million, up 189.71% from a year prior.
  • Liabilities and Shareholders Equity hit $34.1 million in Q3 2025 for Myomo, down from $38.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $42.2 million in Q4 2024 to a low of $10.2 million in Q4 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $17.1 million (2023), compared with a mean of $20.8 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: plummeted 49.43% in 2022 and later skyrocketed 189.71% in 2024.
  • Myomo's Liabilities and Shareholders Equity stood at $20.1 million in 2021, then plummeted by 49.43% to $10.2 million in 2022, then soared by 43.49% to $14.6 million in 2023, then skyrocketed by 189.71% to $42.2 million in 2024, then dropped by 19.33% to $34.1 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $34.1 million (Q3 2025), $38.7 million (Q2 2025), and $40.9 million (Q1 2025) per Business Quant data.